Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to ...

attorneys for the company said they were blocking tree cutting for a pipeline that has been approved by various regulatory agencies. Supporters of the $3.7 billion project say it will bring jobs ...

The body’s immune system is responsible for fighting off foreign invaders, such as harmful viruses and bacteria. It’s our own personal defense army. But the immune system may get confused for ...

The company has proposed a 41-mile (66-kilometer) reroute of the pipeline to end its dispute with the Bad River Band of Lake Superior Chippewa The state's three-person Public Service Commission ...

Risky corporate credit markets have expanded rapidly since the global financial crisis. The role of nonbank financial institutions has increased, and the system has become more complex and opaque.